Tag: Syndax Pharmaceuticals

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Syndax Pharmaceuticals

Syndax Pharmaceuticals (NASDAQ:SNDX) Coverage Initiated at Robert W. Baird

Added to Collection on: 2019-01-29 08:11:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
ValuEngine Downgrades Syndax Pharmaceuticals (SNDX) to Sell

Added to Collection on: 2019-02-05 19:52:07

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Syndax Pharmaceuticals (NASDAQ:SNDX) Cut to “Sell” at ValuEngine

Added to Collection on: 2019-02-27 11:45:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Syndax Pharmaceuticals (SNDX) Given a $26.00 Price Target by B. Riley Analysts

Added to Collection on: 2019-03-10 18:07:06

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Morgan Stanley Analysts Give Syndax Pharmaceuticals (SNDX) a $5.00 Price Target

Added to Collection on: 2019-03-17 22:05:39

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Syndax Pharmaceuticals (NASDAQ:SNDX) Given a $26.00 Price Target by B. Riley Analysts

Added to Collection on: 2019-03-25 15:59:35

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Syndax Pharmaceuticals (NASDAQ:SNDX) Rating Increased to Hold at ValuEngine

Added to Collection on: 2019-03-28 11:11:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Syndax Pharmaceuticals' (NASDAQ:SNDX) “Buy” Rating Reaffirmed at HC Wainwright

Added to Collection on: 2019-03-30 07:15:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Syndax Pharmaceuticals (NASDAQ:SNDX) PT Raised to $16.00

Added to Collection on: 2019-04-03 07:26:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Syndax Pharmaceuticals (NASDAQ:SNDX) Upgraded to “Hold” at ValuEngine

Added to Collection on: 2019-04-08 11:56:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details